Plain-English translation of NCT06182436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether virtual reality can help children feel calmer and experience less pain during dupilumab injections. Dupilumab is a highly effective medication for atopic dermatitis (a common inflammatory skin condition), but some children find the injection itself painful and anxiety-provoking. Researchers want to see if wearing a VR headset for a few minutes before the injection makes the experience easier.
While this medication works very well, many children struggle with fear and pain during the injection itself—even though the shot only lasts a few seconds. Previous strategies like numbing cream haven't always worked well. Early research suggests that virtual reality can distract from pain in other medical situations, so researchers want to test if it could help during these injections.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. One group will use a virtual reality headset for about five minutes before receiving the injection—you'll play an engaging game to distract yourself. The other group will receive the injection without any special distraction. Either way, you'll still get the medication you need for your skin condition; the study is simply testing whether the VR experience makes the injection less scary and painful.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada